PORT WASHINGTON, N.Y.--(BUSINESS WIRE)--ForteBio, a division of Pall Life Sciences and a leading supplier of instrumentation for accelerated drug discovery and development, today announced the launch ...
MENLO PARK, Calif., March 3 /PRNewswire/ -- ForteBio(R), Inc., a leading supplier of label-free technology that accelerates the development of biotherapeutic and pharmaceutical products, today ...
Understanding the affinity, binding kinetics, and mechanism of binding can provide key insights into the desirability of a drug candidate. The affinity of an interaction directly affects the dose ...
Innovative label-free technologies such as biolayer interferometry (BLI) and advances in biosensor technology over the past several years have been addressing the growing demand and requirements for ...
HPLC has long been regarded as the standard for antibody quantitation. It is extensively used in drug development processes to quantitate antibodies in cell culture supernatants, fed-batch flasks, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results